14-day Premium Trial Subscription Try For FreeGet Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of HALO
Powered by GPT-4
Stock Analysis
Risk Assessment
Trading Strategy

Halozyme Therapeutics stock price down 0.49813200498131% on Friday
(Updated on Dec 08, 2023)

Hold candidate since Nov 30, 2023 Gain 3.47% PDF
The Halozyme Therapeutics stock price fell by -0.49813200498131% on the last day (Friday, 8th Dec 2023) from $40.15 to $39.95. During the last trading day the stock fluctuated 4.04% from a day low at $39.47 to a day high of $41.06. The price has risen in 6 of the last 10 days but is still down by -1.06% for this period. Volume has increased on the last day by 93 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 732 thousand shares were bought and sold for approximately $29.26 million.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Halozyme Therapeutics stock with a 90% probability to be traded between $34.11 and $42.23 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

HALO Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Monday, November 27, 2023, and so far it has fallen -2.23%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. The Halozyme Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $39.77 and $37.58. A breakdown below any of these levels will issue sell signals.

Special Signal Notification

Double Top Formation

Double Top Formation A sell signal from a double top formation was found on Monday, November 27, 2023 and based on theory for this formation the price should fall by -29.24% to $28.27 within 52 trading days since signal was issued (Monday, December 11, 2023).

Maximize Your Market Edge: Go Premium for In-Depth AI-Powered Stock Research and Exclusive Lists! 🚀

Support, Risk & Stop-loss for Halozyme Therapeutics stock

Halozyme Therapeutics finds support from accumulated volume at $39.22 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.59 between high and low, or 4.04%. For the last week, the stock has had daily average volatility of 2.79%.

Our recommended stop-loss: $38.56 (-3.49%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 9 days ago.)

Trading Expectations (HALO) For The Upcoming Trading Day Of Monday 11th

For the upcoming trading day on Monday, 11th we expect Halozyme Therapeutics to open at $40.16, and during the day (based on 14 day Average True Range), to move between $38.59 and $41.31, which gives a possible trading interval of +/-$1.36 (+/-3.40%) up or down from last closing price. If Halozyme Therapeutics takes out the full calculated possible swing range there will be an estimated 6.80% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $40.11 (0.40%) than the support at $39.22 (1.83%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Halozyme Therapeutics stock A Buy?

Halozyme Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.338 Open Broker Account

Hold/Accumulate Unchanged

Predicted Opening Price for Halozyme Therapeutics of Monday, December 11, 2023

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Fair opening price December 11, 2023 Current price
$40.16 $39.95 (Undervalued)

Remember To Visit Our YouTube Channel

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 41.76 4.52 %
R2 41.15 3.00 %
R1 40.77 2.05 %
Current price: 39.95
Support S1 39.55 -1.00 %
S2 39.18 -1.94 %
S3 38.57 -3.46 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 41.03 2.70 %
R2 40.29 0.85 %
R1 40.11 0.401 %
Current price 39.95
Support S1 39.22 -1.83%
S2 38.80 -2.88%
S3 37.50 -6.13%
What is the symbol for Halozyme Therapeutics Stock and on which exchange is it traded?
The symbol for Halozyme Therapeutics is HALO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Halozyme Therapeutics Stock?
Halozyme Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Halozyme Therapeutics Stock?
Halozyme Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Halozyme Therapeutics Stock.

What's the current price of Halozyme Therapeutics Stock?
As of the end of day on the 2023-12-08, the price of an Halozyme Therapeutics (HALO) share was $39.95.

What is the 52-week high and low for Halozyme Therapeutics Stock?
The 52-week high for Halozyme Therapeutics Stock is $59.40 and the 52-week low is $29.85.

What is the market capitalization of Halozyme Therapeutics Stock?
As of the 2023-12-08, the market capitalization of Halozyme Therapeutics is 5.277B.

When is the next earnings date for Halozyme Therapeutics?
The upcoming earnings date for Halozyme Therapeutics is 2024-02-20 00:00:00.

Click to get the best stock tips daily for free!

About Halozyme Therapeutics

Halozyme Therapeutics Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules a... HALO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE